Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ursini

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Investigation|December 22, 2017
Response to the letter to the editor by Shadmani et alFrancesco Ursini
Reviews on Recent Clinical Trials|December 1, 2017
The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical EvidenceFrancesco Ursini, Ludovico Abenavoli
Reviews on Recent Clinical Trials|August 8, 2018
Cardiometabolic Comorbidities in Autoimmune Rheumatic Diseases: From Pathogenesis to TreatmentFrancesco Ursini, Piero Ruscitti
Arthritis & Rheumatology (Hoboken, N.J.)|May 7, 2026
Commentary on: "Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial"Jacopo Ciaffi, Francesco Ursini
Clinical and Experimental Rheumatology|January 27, 2022
Reply to: Real-world Coronavirus disease-19 vaccine hesitancy in systemic sclerosisJacopo Ciaffi, Francesco Ursini
Diabetes, Obesity & Metabolism|June 3, 2026
Could Incretin-Based Weight Loss Unmask a Modifiable Nociplastic Pain Phenotype? A Rheumatological Reading of SURMOUNT-5Jacopo Ciaffi, Roberto Caporali, Francesco Ursini
Journal of Psychosomatic Research|March 23, 2023
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?Piero Ruscitti, Francesco Ursini, Yehuda Shoenfeld
RMD Open|September 24, 2025
If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?Francesco Ursini, Jacopo Ciaffi, Roberto Caporali
International Journal of Surgery (London, England)|March 31, 2020
Revenge lawsuit is a puzzle piece of the global crisis of Italian healthcare systemFrancesco Pata, Francesco Ursini, Gaetano Gallo
Rheumatology (Oxford, England)|July 1, 2026
Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platformJacopo Ciaffi, Roberto Caporali, Francesco Ursini
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Investigation|December 22, 2017
Response to the letter to the editor by Shadmani et alFrancesco Ursini
Reviews on Recent Clinical Trials|December 1, 2017
The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical EvidenceFrancesco Ursini, Ludovico Abenavoli
Reviews on Recent Clinical Trials|August 8, 2018
Cardiometabolic Comorbidities in Autoimmune Rheumatic Diseases: From Pathogenesis to TreatmentFrancesco Ursini, Piero Ruscitti
Arthritis & Rheumatology (Hoboken, N.J.)|May 7, 2026
Commentary on: "Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial"Jacopo Ciaffi, Francesco Ursini
Clinical and Experimental Rheumatology|January 27, 2022
Reply to: Real-world Coronavirus disease-19 vaccine hesitancy in systemic sclerosisJacopo Ciaffi, Francesco Ursini
Diabetes, Obesity & Metabolism|June 3, 2026
Could Incretin-Based Weight Loss Unmask a Modifiable Nociplastic Pain Phenotype? A Rheumatological Reading of SURMOUNT-5Jacopo Ciaffi, Roberto Caporali, Francesco Ursini
Journal of Psychosomatic Research|March 23, 2023
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?Piero Ruscitti, Francesco Ursini, Yehuda Shoenfeld
RMD Open|September 24, 2025
If the evidence is there, why are GLP-1 receptor agonists not on-label for hip and knee osteoarthritis in overweight patients?Francesco Ursini, Jacopo Ciaffi, Roberto Caporali
International Journal of Surgery (London, England)|March 31, 2020
Revenge lawsuit is a puzzle piece of the global crisis of Italian healthcare systemFrancesco Pata, Francesco Ursini, Gaetano Gallo
Rheumatology (Oxford, England)|July 1, 2026
Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using the TriNetX research platformJacopo Ciaffi, Roberto Caporali, Francesco Ursini
Pageof 18